Skip to content

Drug interactions

Erdafitinib + Oxaliplatin

Severity: Moderate

Erdafitinib and Oxaliplatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib inhibits the renal transporter OCT2, which contributes to oxaliplatin uptake and elimination. Co-administration might raise oxaliplatin exposure and toxicity, though clinical data are limited.

What this interaction means in plain words

Erdafitinib and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Oxaliplatin belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of OCT2-mediated renal transport reduces oxaliplatin clearance.

What to do

Monitor for increased oxaliplatin toxicity, including neuropathy and myelosuppression. Consider dose reduction of oxaliplatin based on tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Oxaliplatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Oxaliplatin?

MediHelp rates the interaction as moderate. Erdafitinib and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib inhibits the renal transporter OCT2, which contributes to oxaliplatin uptake and elimination. Co-administration might raise oxaliplatin exposure and toxicity, though clinical data are limited.

How serious is the interaction between Erdafitinib and Oxaliplatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for increased oxaliplatin toxicity, including neuropathy and myelosuppression. Consider dose reduction of oxaliplatin based on tolerability.

What other medicines interact with Oxaliplatin?

MediHelp also lists interactions of Oxaliplatin with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Oxaliplatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in